Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Pediatric Cardiac Surgery
NCT00451698Phase 2Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2007
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in congenital heart defect (CHD), sponsored by Medical College of Wisconsin. Started Oct 2007; status: terminated.
02
Drugs
erythropoietin
03
Conditions
congenital heart defect (CHD)
Beyond the preview
Go deeper on NCT00451698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451698.